6851 - 6875 of 7730 Results
Title
Year
-
RESTRICTEDTitle: The Role of Stable α-Synuclein Oligomers in the Molecular Events Underlying Amyloid FormationJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 136Issue #: 10Start Page: 3859End Page: 3868Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/ja411577tCitation Count: 221
-
RESTRICTEDTitle: Atypical presentation of late‐onset Tay‐sachs diseaseJournal Name: Muscle & NervePublisher: WileyVol: 49Issue #: 5Start Page: 768End Page: 771Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mus.24146Best OA location URL: https://europepmc.org/articles/pmc4346308?pdf=renderCitation Count: 29
-
RESTRICTEDTitle: Prodromal features for Parkinson's disease – baseline data from the TREND studyJournal Name: European Journal of NeurologyPublisher: WileyVol: 21Issue #: 5Start Page: 766End Page: 772Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.12382Citation Count: 103
- Resting state functional MRI in Parkinson’s disease: the impact of deep brain stimulation on ‘effective’ connectivity2014RESTRICTEDTitle: Resting state functional MRI in Parkinson’s disease: the impact of deep brain stimulation on ‘effective’ connectivityJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 137Issue #: 4Start Page: 1130End Page: 1144Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awu027Best OA location URL: https://academic.oup.com/brain/article-pdf/137/4/1130/13799493/awu027.pdfCitation Count: 194
- Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients2014RESTRICTEDTitle: Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patientsJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 124Issue #: 3Start Page: 1340End Page: 1349Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1172/jci71640Best OA location URL: http://www.jci.org/articles/view/71640/files/pdfCitation Count: 210
- Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials2014RESTRICTEDTitle: Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trialsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 127Issue #: 6Start Page: 861End Page: 879Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-014-1256-4Best OA location URL: https://europepmc.org/articles/pmc4034750?pdf=renderCitation Count: 199
-
RESTRICTEDTitle: The effect of deep brain stimulation randomized by site on balance in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 7Start Page: 949End Page: 953Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25831Best OA location URL: https://europepmc.org/articles/pmc4057940?pdf=renderCitation Count: 39
- Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease2014RESTRICTEDTitle: Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 111Issue #: 7Start Page: 2626End Page: 2631Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1073/pnas.1318306111Best OA location URL: https://www.pnas.org/content/pnas/111/7/2626.full.pdfCitation Count: 334
-
RESTRICTEDTitle: Heterogeneity in primary dystonia: Lessons from THAP1, GNAL, and TOR1A in Amish‐MennonitesJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 812End Page: 818Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25818Best OA location URL: https://europepmc.org/articles/pmc4013240?pdf=renderCitation Count: 36
-
RESTRICTEDTitle: Cheek cell–derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from controlJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 2Start Page: 418End Page: 420Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.08.008Best OA location URL: https://escholarship.org/content/qt8m97s2kf/qt8m97s2kf.pdf?t=rsqp1sCitation Count: 29
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study2014RESTRICTEDTitle: Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 13Issue #: 2Start Page: 141End Page: 149Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(13)70293-xBest OA location URL: https://europepmc.org/articles/pmc4643396?pdf=renderCitation Count: 563
- Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian rats2014RESTRICTEDTitle: Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 77Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.09.017Best OA location URL: https://europepmc.org/articles/pmc3865178?pdf=renderCitation Count: 57
- Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury2014RESTRICTEDTitle: Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 10Issue #: 1SStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2013.12.011Best OA location URL: https://europepmc.org/articles/pmc4201593?pdf=renderCitation Count: 64
-
RESTRICTEDTitle: Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 2Start Page: 141End Page: 141Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2013.5528Best OA location URL: https://europepmc.org/articles/pmc3940333?pdf=renderCitation Count: 202
- Oxidation-induced Structural Changes of Ceruloplasmin Foster NGR Motif Deamidation That Promotes Integrin Binding and Signaling2014RESTRICTEDTitle: Oxidation-induced Structural Changes of Ceruloplasmin Foster NGR Motif Deamidation That Promotes Integrin Binding and SignalingJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 289Issue #: 6Start Page: 3736End Page: 3748Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.m113.520981Best OA location URL: http://www.jbc.org/article/S0021925819747607/pdfCitation Count: 28
-
RESTRICTEDTitle: Pooled analysis of iron-related genes in Parkinson's disease: Association with transferrinJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 62Issue #:Start Page: 172End Page: 178Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2013.09.019Best OA location URL: https://europepmc.org/articles/pmc3968945?pdf=renderCitation Count: 73
- The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation2014RESTRICTEDTitle: The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 62Issue #:Start Page: 233End Page: 240Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2013.09.021Best OA location URL: https://lup.lub.lu.se/search/files/1604585/4934203.pdfCitation Count: 16
-
RESTRICTEDTitle: Treatment of Psychosis and Dementia in Parkinson’s DiseaseJournal Name: Current Treatment Options in NeurologyPublisher: Springer Science and Business Media LLCVol: 16Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11940-013-0281-2Best OA location URL: https://europepmc.org/articles/pmc3994190?pdf=renderCitation Count: 107
- Clinical Comparison of 99mTc Exametazime and 123I Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain Injury2014RESTRICTEDTitle: Clinical Comparison of 99mTc Exametazime and 123I Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain InjuryJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 1Start Page: e87009End Page: e87009Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0087009Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0087009&type=printableCitation Count: 14
- ALS-FTD Complex Disorder due to <b><i>C9ORF72</i></b> Gene Mutation: Description of First Polish Family2014RESTRICTEDTitle: ALS-FTD Complex Disorder due to <b><i>C9ORF72</i></b> Gene Mutation: Description of First Polish FamilyJournal Name: European NeurologyPublisher: S. Karger AGVol: 72Issue #: 1-2Start Page: 64End Page: 71Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1159/000362267Best OA location URL: https://karger.com/ene/article-pdf/72/1-2/64/2724525/000362267.pdfCitation Count: 1
-
RESTRICTEDTitle: Blood-based biomarkers for Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #:Start Page: S99End Page: S103Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1353-8020(13)70025-7Best OA location URL: https://europepmc.org/articles/pmc4070332?pdf=renderCitation Count: 123
- Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson’s disease2014RESTRICTEDTitle: Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson’s diseaseJournal Name: NeurosciencePublisher: Elsevier BVVol: 258Issue #:Start Page: 385End Page: 400Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2013.11.038Best OA location URL: https://europepmc.org/articles/pmc3923582?pdf=renderCitation Count: 44
-
RESTRICTEDTitle: Continuous in-home monitoring of essential tremorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 1Start Page: 37End Page: 40Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2013.09.009Best OA location URL: https://europepmc.org/articles/pmc3946846?pdf=renderCitation Count: 62
-
RESTRICTEDTitle: Detraining outcomes with expiratory muscle strength training in Parkinson diseaseJournal Name: Journal of Rehabilitation Research and DevelopmentPublisher: Journal of Rehabilitation Research & DevelopmentVol: 51Issue #: 2Start Page: 305End Page: 310Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1682/jrrd.2013.05.0101Best OA location URL: https://europepmc.org/articles/pmc4644088?pdf=renderCitation Count: 48
-
RESTRICTEDTitle: Development of allosteric modulators of GPCRs for treatment of CNS disordersJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 61Issue #:Start Page: 55End Page: 71Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2013.09.013Best OA location URL: https://doi.org/10.1016/j.nbd.2013.09.013Citation Count: 198